Therefore, these findings suggest that an underlying mechanism of MTFR2/DRP1-mediated mitochondrial fission activated by TP53 mutation exacerbates HCC prognosis via the cell cycle pathway. Here, TP53 is linked to hepatocellular carcinoma.